Dr. Reddy's Laboratories Ltd Company Profile (NYSE:RDY)

About Dr. Reddy's Laboratories Ltd (NYSE:RDY)

Dr. ReddyDr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Pharmaceuticals - NEC
  • Sub-Industry: N/A
  • Symbol: NYSE:RDY
  • CUSIP: N/A
  • Web: www.drreddys.com
Capitalization:
  • Market Cap: $5.097 billion
  • Outstanding Shares: 165,801,000
Average Prices:
  • 50 Day Moving Avg: $37.81
  • 200 Day Moving Avg: $40.55
  • 52 Week Range: $30.22 - $50.10
P/E:
  • Trailing P/E Ratio: 28.77
  • Foreward P/E Ratio: 15.53
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $2.2 billion
  • Price / Sales: 2.32
  • Book Value: $11.62 per share
  • Price / Book: 2.65
Dividend:
  • Annual Dividend: $0.29
  • Dividend Yield: 1.0%
Profitability:
  • EBIDTA: $384.63 million
  • Net Margins: 7.92%
  • Return on Equity: 9.27%
  • Return on Assets: 5.06%
Debt:
  • Debt-to-Equity Ratio: 0.20%
  • Current Ratio: 1.53%
  • Quick Ratio: 1.10%
Misc:
  • Average Volume: 333,616 shs.
  • Beta: 0.33
  • Short Ratio: 12.2
 

Frequently Asked Questions for Dr. Reddy's Laboratories Ltd (NYSE:RDY)

What is Dr. Reddy's Laboratories Ltd's stock symbol?

Dr. Reddy's Laboratories Ltd trades on the New York Stock Exchange (NYSE) under the ticker symbol "RDY."

How often does Dr. Reddy's Laboratories Ltd pay dividends? What is the dividend yield for Dr. Reddy's Laboratories Ltd?

Dr. Reddy's Laboratories Ltd declared a None dividend on Friday, August 4th. Stockholders of record on Monday, July 17th will be given a dividend of $0.294 per share on Thursday, August 10th. The ex-dividend date of this dividend is Thursday, July 13th. View Dr. Reddy's Laboratories Ltd's Dividend History.

How were Dr. Reddy's Laboratories Ltd's earnings last quarter?

Dr. Reddy's Laboratories Ltd (NYSE:RDY) issued its quarterly earnings results on Tuesday, July, 26th. The company reported $0.00 EPS for the quarter. The company earned $479 million during the quarter, compared to the consensus estimate of $557 million. Dr. Reddy's Laboratories Ltd had a return on equity of 9.27% and a net margin of 7.92%. View Dr. Reddy's Laboratories Ltd's Earnings History.

When will Dr. Reddy's Laboratories Ltd make its next earnings announcement?

Dr. Reddy's Laboratories Ltd is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for Dr. Reddy's Laboratories Ltd.

Who are some of Dr. Reddy's Laboratories Ltd's key competitors?

Who are Dr. Reddy's Laboratories Ltd's key executives?

Dr. Reddy's Laboratories Ltd's management team includes the folowing people:

  • Satish K. Reddy, Chairman of the Board
  • G. V. Prasad, Co-Chairman of the Board, Chief Executive Officer, Managing Director
  • Saumen Chakraborty, President, Chief Financial Officer, Global Head - HR and IT & BPE
  • Sripada Chandrasekhar Ph.D., President, Global Head - Human Resources
  • Abhijit Mukherjee, Chief Operating Officer
  • Amit Biswas, Executive Vice President and Head - Integrated Product Development
  • Raghav Chari, Executive Vice President and Head - Proprietary Products
  • Samiran Das, Executive Vice President and Head - Global Manufacturing Operations
  • M. V. Ramana, Executive Vice President and Head-Branded Markets - India & Emerging Markets
  • Cartikeya Reddy, Executive Vice President and Head-Biologics

Who owns Dr. Reddy's Laboratories Ltd stock?

Dr. Reddy's Laboratories Ltd's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Fisher Asset Management LLC (3.38%), Royal Bank of Canada (2.09%), Commonwealth Bank of Australia (2.08%), Vanguard Group Inc. (0.89%), State Street Corp (0.38%) and Dimensional Fund Advisors LP (0.35%). View Institutional Ownership Trends for Dr. Reddy's Laboratories Ltd.

Who sold Dr. Reddy's Laboratories Ltd stock? Who is selling Dr. Reddy's Laboratories Ltd stock?

Dr. Reddy's Laboratories Ltd's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., JPMorgan Chase & Co., US Bancorp DE, LMR Partners LLP, Acadian Asset Management LLC, Russell Investments Group Ltd., OxFORD Asset Management LLP and Schroder Investment Management Group. View Insider Buying and Selling for Dr. Reddy's Laboratories Ltd.

Who bought Dr. Reddy's Laboratories Ltd stock? Who is buying Dr. Reddy's Laboratories Ltd stock?

Dr. Reddy's Laboratories Ltd's stock was acquired by a variety of institutional investors in the last quarter, including Royal Bank of Canada, First Trust Advisors LP, Commonwealth Bank of Australia, State Street Corp, Prudential Financial Inc., Segantii Capital Management Ltd, Fisher Asset Management LLC and Mitsubishi UFJ Trust & Banking Corp. View Insider Buying and Selling for Dr. Reddy's Laboratories Ltd.

How do I buy Dr. Reddy's Laboratories Ltd stock?

Shares of Dr. Reddy's Laboratories Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dr. Reddy's Laboratories Ltd's stock price today?

One share of Dr. Reddy's Laboratories Ltd stock can currently be purchased for approximately $30.75.


MarketBeat Community Rating for Dr. Reddy's Laboratories Ltd (NYSE RDY)
Community Ranking:  1.9 out of 5 ()
Outperform Votes:  72 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  192
MarketBeat's community ratings are surveys of what our community members think about Dr. Reddy's Laboratories Ltd and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Dr. Reddy's Laboratories Ltd (NYSE:RDY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating
Consensus Rating:Hold (Score: 1.50)
Consensus Price Target: N/A

Analysts' Ratings History for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/28/2017CLSADowngradeUnderperform -> SellLowView Rating Details
5/15/2017Deutsche Bank AGUpgradeSell -> HoldHighView Rating Details
7/27/2016HSBC Holdings plcDowngradeHold -> ReduceN/AView Rating Details
7/27/2016Jefferies Group LLCDowngradeHold -> Underperform$45.00 -> $41.90N/AView Rating Details
7/26/2016Credit Suisse GroupDowngradeNeutral -> UnderperformN/AView Rating Details
5/2/2016Goldman Sachs Group, Inc. (The)Initiated CoverageNeutralN/AView Rating Details
11/10/2015Citigroup Inc.DowngradeBuy -> NeutralN/AView Rating Details
11/6/2015Barclays PLCDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 8/20/2015 forward)

Earnings

Earnings History for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Earnings by Quarter for Dr. Reddy`s Laboratories Ltd (NYSE:RDY)
Earnings History by Quarter for Dr. Reddy's Laboratories Ltd (NYSE RDY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017        
7/26/2016Q117$0.00$557.00 million$479.00 millionViewListenView Earnings Details
5/12/2016Q416$0.07$2.41 billion$567.00 billionViewListenView Earnings Details
2/9/2016Q316$0.51$2.48 million$599.00 millionViewN/AView Earnings Details
10/29/2015Q116$0.65$2.54 billion$609.00 millionViewListenView Earnings Details
5/12/2015Q415$0.49$559.00 million$621.00 millionViewListenView Earnings Details
1/29/2015Q315$0.53$561.00 million$610.00 millionViewN/AView Earnings Details
7/30/2014Q115$0.54$474.00 million$486.00 millionViewN/AView Earnings Details
5/13/2014Q414$0.52$0.47$557.00 million$580.00 millionViewN/AView Earnings Details
2/11/2014Q314$0.45$0.59$558.20 million$571.00 millionViewN/AView Earnings Details
10/31/2013Q214$0.46$0.65$561.00 million$537.00 millionViewN/AView Earnings Details
7/30/2013Q413$0.43$0.40$551.40 million$478.00 millionViewN/AView Earnings Details
5/14/2013$0.60ViewN/AView Earnings Details
2/14/2013Q313$0.40$505.00 million$522.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Current Year EPS Consensus Estimate: $1.28 EPS
Next Year EPS Consensus Estimate: $1.98 EPS

Dividends

Current Dividend Information for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Most Recent Dividend:8/10/2017
Annual Dividend:$0.29
Dividend Yield:0.94%
Dividend Growth:7.40% (3 Year Average)
Payout Ratio:27.88% (Trailing 12 Months of Earnings)
22.66% (Based on This Year's Estimates)
14.65% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Dr. Reddy`s Laboratories Ltd (NYSE:RDY)

Dividend History by Quarter for Dr. Reddy's Laboratories Ltd (NYSE RDY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/4/2017None$0.297/13/20177/17/20178/10/2017
6/6/2017$0.297/13/20177/17/20177/17/2017
6/6/2016Annual$0.287/14/20167/18/20167/18/2016
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Latest Headlines for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Source:
DateHeadline
finance.yahoo.com logoETFs with exposure to Dr. Reddy’s Laboratories Ltd. : August 16, 2017
finance.yahoo.com - August 17 at 7:16 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Dr. Reddy’s Laboratories Limited
finance.yahoo.com - August 15 at 6:38 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Dr. Reddy’s Laboratories Limited
finance.yahoo.com - August 12 at 7:18 AM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 12 at 7:18 AM
businesswire.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Dr ...
www.businesswire.com - August 11 at 7:59 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Ltd. - RDY
finance.yahoo.com - August 11 at 7:59 AM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Dr. Reddy’s Laboratories Ltd. – RDY
finance.yahoo.com - August 11 at 7:59 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Dr. Reddy’s Laboratories Limited
finance.yahoo.com - August 11 at 7:59 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dr. Reddy's Laboratories Ltd. (RDY)
finance.yahoo.com - August 11 at 7:59 AM
finance.yahoo.com logoDR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Dr. Reddy's Laboratories Limited To Contact The Firm
finance.yahoo.com - August 11 at 7:59 AM
nasdaq.com logoDr. Reddy's (RDY) Earnings Decline Y/Y in Q1, Sales Rise - Nasdaq
www.nasdaq.com - August 2 at 3:49 PM
finance.yahoo.com logoDr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q1, 2018 By the Numbers : August 2, 2017
finance.yahoo.com - August 2 at 3:49 PM
americanbankingnews.com logoFY2019 EPS Estimates for Dr. Reddy's Laboratories Ltd (RDY) Reduced by Jefferies Group
www.americanbankingnews.com - July 31 at 10:08 AM
seekingalpha.com logoDr. Reddy's FQ1 results underwhelm investors; shares down 9%
seekingalpha.com - July 29 at 6:42 AM
finance.yahoo.com logoInvestor Network: Dr. Reddy's Laboratories Ltd. to Host Earnings Call
finance.yahoo.com - July 29 at 6:42 AM
finance.yahoo.com logoDoctor Reddy's posts 1Q profit
finance.yahoo.com - July 29 at 6:42 AM
americanbankingnews.com logoDr. Reddy's Laboratories Ltd (NYSE:RDY) Cut to "Sell" at CLSA
www.americanbankingnews.com - July 28 at 5:21 PM
streetinsider.com logoDr. Reddys Labs (RDY), CHD Bioscience Announce Development ... - StreetInsider.com
www.streetinsider.com - July 28 at 7:13 AM
seekingalpha.com logoDr. Reddy's Laboratories' (RDY) Q1 2018 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 28 at 7:13 AM
finance.yahoo.com logoDr. Reddy’s and CHD Bioscience Announce Global License and Commercialization Agreement for Phase III Clinical Trial Candidate for Mitigation of Surgical Site Infections
finance.yahoo.com - July 28 at 7:13 AM
nasdaq.com logoAsian ADRs Move Higher in Monday Trading - Nasdaq
www.nasdaq.com - July 24 at 5:53 PM
businesswire.com logoDr. Reddy's to Release Q1 FY18 Results on July 27, 2017 - Business Wire (press release)
www.businesswire.com - July 16 at 2:33 PM
finance.yahoo.com logoDr. Reddy's to Release Q1 FY18 Results on July 27, 2017
finance.yahoo.com - July 15 at 7:57 AM
americanbankingnews.com logoZacks Investment Research Upgrades Dr. Reddy's Laboratories Ltd (RDY) to Hold
www.americanbankingnews.com - July 14 at 1:24 PM
finance.yahoo.com logoETFs with exposure to Dr. Reddy’s Laboratories Ltd. : July 12, 2017
finance.yahoo.com - July 13 at 8:33 AM
americanbankingnews.com logoDr. Reddy's Laboratories Ltd Declares Dividend of $0.29 (RDY)
www.americanbankingnews.com - July 8 at 11:30 AM
americanbankingnews.com logoDr. Reddy's Laboratories Ltd (NYSE:RDY) Given Consensus Rating of "Sell" by Brokerages
www.americanbankingnews.com - July 4 at 9:18 AM
finance.yahoo.com logoETFs with exposure to Dr. Reddy’s Laboratories Ltd. : June 27, 2017
finance.yahoo.com - June 27 at 7:33 PM
finance.yahoo.com logoDr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q4, 2017 By the Numbers : June 26, 2017
finance.yahoo.com - June 27 at 7:44 AM
americanbankingnews.com logoDr.Reddy's Laboratories Ltd (RDY) Receives Average Recommendation of "Sell" from Analysts
www.americanbankingnews.com - June 9 at 9:05 AM
nasdaq.com logoDr. Reddy's Launches Angiomax' Generic Bivalirudin For Injection In US - Nasdaq
www.nasdaq.com - June 8 at 8:42 AM
businesswire.com logoDr. Reddy's Laboratories Limited to Present at the Jefferies 2017 Global Healthcare Conference - Business Wire (press release)
www.businesswire.com - June 7 at 8:23 AM
rttnews.com logoDr. Reddy's Launches Angiomax' Generic Bivalirudin For Injection In U.S.
www.rttnews.com - June 6 at 8:56 PM
finance.yahoo.com logoDr. Reddy's Laboratories Announces the Launch of Bivalirudin for Injection in the U.S. Market
finance.yahoo.com - June 6 at 8:56 PM
finance.yahoo.com logoDr. Reddy's Laboratories Limited to Present at the Jefferies 2017 Global Healthcare Conference
finance.yahoo.com - June 5 at 8:08 PM
seekingalpha.com logoMarketplace Roundtable: Going Global - Seeking Alpha
seekingalpha.com - May 28 at 12:52 AM
nasdaq.com logoDr. Reddy's Laboratories Enters Oversold Territory (RDY) - Nasdaq
www.nasdaq.com - May 28 at 12:52 AM
americanbankingnews.com logoJefferies Group Comments on Dr.Reddy's Laboratories Ltd's FY2018 Earnings (RDY)
www.americanbankingnews.com - May 17 at 12:50 PM
businesswire.com logoDr. Reddy's Laboratories Announces USFDA Approval for the Launch of Doxorubicin Hydrochloride Liposome Injection ... - Business Wire (press release)
www.businesswire.com - May 17 at 8:00 AM
seekingalpha.com logoDr. Reddy's Laboratories' (RDY) Q4 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 17 at 8:00 AM
finance.yahoo.com logoDr. Reddy's Laboratories Announces USFDA Approval for the Launch of Doxorubicin Hydrochloride Liposome Injection in the U.S. Market
finance.yahoo.com - May 17 at 8:00 AM
americanbankingnews.com logoFY2019 EPS Estimates for Dr.Reddy's Laboratories Ltd Decreased by Analyst (RDY)
www.americanbankingnews.com - May 16 at 1:26 PM
finance.yahoo.com logoDr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q4
finance.yahoo.com - May 15 at 6:42 PM
americanbankingnews.com logoDr.Reddy's Laboratories Ltd (RDY) Given Consensus Rating of "Sell" by Brokerages
www.americanbankingnews.com - May 15 at 10:40 AM
finance.yahoo.com logoDr. Reddy’s Q4 and FY17 Financial Results
finance.yahoo.com - May 12 at 8:48 PM
finance.yahoo.com logoDoctor Reddy's posts 4Q profit
finance.yahoo.com - May 12 at 8:48 PM
americanbankingnews.com logoDr.Reddy's Laboratories (RDY) Getting Somewhat Positive Media Coverage, Analysis Finds
www.americanbankingnews.com - May 1 at 5:36 PM
businesswire.com logoDr. Reddy's Laboratories Announces the Launch of Ezetimibe and Simvastatin Tablets in the U.S. Market - Business Wire (press release)
www.businesswire.com - April 28 at 8:03 AM
finance.yahoo.com logoDr. Reddy's Laboratories Announces the Launch of Ezetimibe and Simvastatin Tablets in the U.S. Market
finance.yahoo.com - April 27 at 10:54 AM
americanbankingnews.com logoDr.Reddy's Laboratories (RDY) Earns News Sentiment Score of 0.69
www.americanbankingnews.com - April 26 at 9:39 AM

Social

Chart

Dr. Reddy's Laboratories Ltd (RDY) Chart for Sunday, August, 20, 2017

This page was last updated on 8/20/2017 by MarketBeat.com Staff